XOMA Corporation (XOMA): Price and Financial Metrics

XOMA POWR Grades

• Value is the dimension where XOMA ranks best; there it ranks ahead of 78.78% of US stocks.
• The strongest trend for XOMA is in Value, which has been heading up over the past 48 weeks.
• XOMA's current lowest rank is in the Growth metric (where it is better than 9.48% of US stocks).

XOMA Stock Summary

• For XOMA, its debt to operating expenses ratio is greater than that reported by just 6.36% of US equities we're observing.
• With a year-over-year growth in debt of -98.99%, XOMA Corp's debt growth rate surpasses just 1.6% of about US stocks.
• As for revenue growth, note that XOMA's revenue has grown 179.47% over the past 12 months; that beats the revenue growth of 96.11% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to XOMA Corp, a group of peers worth examining would be CRTD, BEEM, PLAG, FNV, and FSM.
• XOMA's SEC filings can be seen here. And to visit XOMA Corp's official web site, go to www.xoma.com.

XOMA Valuation Summary

• XOMA's price/sales ratio is 12; this is 215.79% higher than that of the median Healthcare stock.
• Over the past 243 months, XOMA's price/sales ratio has gone down 69.
• XOMA's price/sales ratio has moved down 69 over the prior 243 months.

Below are key valuation metrics over time for XOMA.

XOMA Growth Metrics

• The 4 year net income to common stockholders growth rate now stands at -42.35%.
• Its year over year price growth rate is now at 31.07%.
• Its 3 year revenue growth rate is now at -77.15%.

XOMA's revenue has moved up $20,443,000 over the prior 33 months.

The table below shows XOMA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	29.414	10.353	10.156
2021-03-31	28.957	11.458	10.153
2020-12-31	29.385	10.092	13.298
2020-09-30	2.227	-11.734	-12.712
2020-06-30	10.525	-5.499	-9.784
2020-03-31	11.043	-5.722	-10.323

XOMA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XOMA has a Quality Grade of C, ranking ahead of 61.51% of graded US stocks.
• XOMA's asset turnover comes in at 0.252 -- ranking 175th of 677 Pharmaceutical Products stocks.
• VBLT, SRNE, and CNCE are the stocks whose asset turnover ratios are most correlated with XOMA.

The table below shows XOMA's key quality metrics over time.